JPWO2022202930A1 - - Google Patents
Info
- Publication number
- JPWO2022202930A1 JPWO2022202930A1 JP2023509266A JP2023509266A JPWO2022202930A1 JP WO2022202930 A1 JPWO2022202930 A1 JP WO2022202930A1 JP 2023509266 A JP2023509266 A JP 2023509266A JP 2023509266 A JP2023509266 A JP 2023509266A JP WO2022202930 A1 JPWO2022202930 A1 JP WO2022202930A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Dispersion Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163164581P | 2021-03-23 | 2021-03-23 | |
| PCT/JP2022/013676 WO2022202930A1 (ja) | 2021-03-23 | 2022-03-23 | 組成物および医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2022202930A1 true JPWO2022202930A1 (https=) | 2022-09-29 |
Family
ID=83395709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023509266A Pending JPWO2022202930A1 (https=) | 2021-03-23 | 2022-03-23 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2022202930A1 (https=) |
| WO (1) | WO2022202930A1 (https=) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015524844A (ja) * | 2012-08-13 | 2015-08-27 | シーダーズ−サイナイ・メディカル・センターＣｅｄａｒｓ−Ｓｉｎａｉ Ｍｅｄｉｃａｌ Ｃｅｎｔｅｒ | 組織再生のためのエキソソームおよびマイクロリボ核酸 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA39990A (fr) * | 2014-05-16 | 2015-11-19 | Univ Pennsylvania | Induction de régénération cardiaque par micro-arn |
-
2022
- 2022-03-23 WO PCT/JP2022/013676 patent/WO2022202930A1/ja not_active Ceased
- 2022-03-23 JP JP2023509266A patent/JPWO2022202930A1/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015524844A (ja) * | 2012-08-13 | 2015-08-27 | シーダーズ−サイナイ・メディカル・センターＣｅｄａｒｓ−Ｓｉｎａｉ Ｍｅｄｉｃａｌ Ｃｅｎｔｅｒ | 組織再生のためのエキソソームおよびマイクロリボ核酸 |
Non-Patent Citations (6)
| Title |
|---|
| DEVALLIERE, JULIE ET AL.: "Sustained delivery of proangiogenic microRNA-132 by nanoparticle transfection improves endothelial c", FASEB JOURNAL, vol. 28, no. 2, JPN6022020174, 2014, pages 908 - 922, ISSN: 0005796916 * |
| HIRAI, KENTA ET AL.: "Cardiosphere-derived exosomal microRNAs for myocardial repair in pediatric dilated cardiomyopathy", SCIENCE TRANSLATIONAL MEDICINE, vol. 12, no. 573, JPN6022020171, 2020, pages 3336 - 1, ISSN: 0005796917 * |
| LEE, SHARON WEI LING ET AL.: "MicroRNA delivery through nanoparticles", JOURNAL OF CONTROLLED RELEASE, vol. 313, JPN6022020175, 2019, pages 80 - 95, ISSN: 0005796915 * |
| LIU, XUELEI ET AL.: "The Role of miRNA-132 against Apoptosis and Oxidative Stress in Heart Failure", BIOMED RESEARCH INTERNATIONAL, vol. 2018, JPN6022020176, 2018, pages 3452748 - 1, ISSN: 0005796914 * |
| MA, TENG ET AL.: "MicroRNA-132, Delivered by Mesenchymal Stem Cell-Derived Exosomes, Promote Angiogenesis in Myocardia", STEM CELLS INTERNATIONAL, vol. 2018, JPN6022020178, 2018, pages 3290372 - 1, ISSN: 0005796912 * |
| ZHAO, ZONGLEI ET AL.: "microRNA-132 inhibits cardiomyocyte apoptosis and myocardial remodeling in myocardial infarction by", JOURNAL OF CELLULAR PHYSIOLOGY, vol. 235, no. 3, JPN6022020177, 2020, pages 2710 - 2721, ISSN: 0005796913 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022202930A1 (ja) | 2022-09-29 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240911 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250924 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20260217 |